Shopping Cart
- Remove All
- Your shopping cart is currently empty
J208 is a dual inhibitor of histone deacetylase (HDAC) and DNA methyltransferase (DNMT) that hinders cancer cell proliferation and the migration/invasion of triple-negative breast cancer (TNBC) cells. It induces apoptosis and causes cell cycle arrest at the G0/G1 phase. Additionally, J208 activates the innate immune signaling pathway in TNBC by inducing the expression of endogenous retroviruses (ERVs) [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | J208 is a dual inhibitor of histone deacetylase (HDAC) and DNA methyltransferase (DNMT) that hinders cancer cell proliferation and the migration/invasion of triple-negative breast cancer (TNBC) cells. It induces apoptosis and causes cell cycle arrest at the G0/G1 phase. Additionally, J208 activates the innate immune signaling pathway in TNBC by inducing the expression of endogenous retroviruses (ERVs) [1]. |
Molecular Weight | 412.44 |
Formula | C20H24N6O4 |
Cas No. | 2116468-11-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.